Serum B cell activating factor (BAFF) and sarcoidosis activity

Area of Science:

• Immunology
• Pulmonology
• Rheumatology

Background:

• Sarcoidosis is a multisystem inflammatory disease of unknown etiology.
• B-cell activating factor (BAFF) is a cytokine crucial for B-cell survival and function, implicated in various autoimmune and inflammatory conditions.

Purpose of the Study:

• To investigate the relationship between serum B-cell activating factor (BAFF) concentrations and the severity of sarcoidosis.
• To compare BAFF levels in patients with acute sarcoidosis versus active chronic sarcoidosis.

Main Methods:

• A cross-sectional study involving 55 sarcoidosis patients and 28 healthy controls.
• Patients were categorized into acute sarcoidosis and active chronic sarcoidosis groups based on clinical, radiological, and pathological findings.
• Serum BAFF levels were measured and compared between groups; disease severity was assessed using clinical parameters and Scadding score.

Main Results:

• Serum BAFF concentrations were significantly higher in both acute sarcoidosis and active chronic sarcoidosis groups compared to healthy controls (p<0.001).
• No significant difference in mean BAFF levels was observed between the acute and active chronic sarcoidosis groups (p=0.351).
• Factors associated with disease activity, such as calcium levels and forced vital capacity, were higher in the acute group, but none correlated significantly with BAFF levels.

Conclusions:

• Serum BAFF is elevated in patients with sarcoidosis, indicating its potential involvement in the disease pathogenesis.
• Elevated BAFF levels in sarcoidosis patients did not correlate with disease severity or differentiate between acute and chronic forms.
• Further research is needed to elucidate the precise role of BAFF in sarcoidosis progression and its potential as a therapeutic target.